Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Duffaud

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Mutation Research|September 26, 2002
Acentromeric micronuclei are increased in peripheral blood lymphocytes of untreated cancer patientsM Baciuchka-Palmaro, T Orsière, F Duffaud, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2012
Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysisM Montemurro, H Gelderblom, U Bitz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancerF Caponigro, C Dittrich, J B Sorensen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group studyF Duffaud, M Borner, P Chollet, et al.
European Journal of Cancer Care|February 13, 2010
A study of 28 flat bone osteosarcomas: prognostic factors and early and long-term outcomeS Salas, T-K Huynh, R Giorgi, et al.
Bulletin Du Cancer|November 20, 2001
[Nutritional workshops for cancer patients: a pilot approach]J L Mouysset, M Baciuchka-Palmaro, M Ichou, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 24, 2017
Patterns of care and clinical outcomes in primary oesophageal gastrointestinal stromal tumours (GIST): A retrospective study of the French Sarcoma Group (FSG)F Duffaud, P Meeus, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survivalD Garbay, R G Maki, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2013
GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative StudyA Italiano, A Le Cesne, C Bellera, et al.
ESMO Open|May 24, 2025
COREGO: drug-drug interaction analysis on the efficacy and safety of regorafenib in patients with a sarcoma: pooled analysis of the data from the REGOSARC and REGOBONE trialsF Rethouze, S Risbourg, C Schiffler, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Mutation Research|September 26, 2002
Acentromeric micronuclei are increased in peripheral blood lymphocytes of untreated cancer patientsM Baciuchka-Palmaro, T Orsière, F Duffaud, et al.
European Journal of Cancer (Oxford, England : 1990)|November 13, 2012
Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysisM Montemurro, H Gelderblom, U Bitz, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancerF Caponigro, C Dittrich, J B Sorensen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group studyF Duffaud, M Borner, P Chollet, et al.
European Journal of Cancer Care|February 13, 2010
A study of 28 flat bone osteosarcomas: prognostic factors and early and long-term outcomeS Salas, T-K Huynh, R Giorgi, et al.
Bulletin Du Cancer|November 20, 2001
[Nutritional workshops for cancer patients: a pilot approach]J L Mouysset, M Baciuchka-Palmaro, M Ichou, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 24, 2017
Patterns of care and clinical outcomes in primary oesophageal gastrointestinal stromal tumours (GIST): A retrospective study of the French Sarcoma Group (FSG)F Duffaud, P Meeus, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survivalD Garbay, R G Maki, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2013
GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative StudyA Italiano, A Le Cesne, C Bellera, et al.
ESMO Open|May 24, 2025
COREGO: drug-drug interaction analysis on the efficacy and safety of regorafenib in patients with a sarcoma: pooled analysis of the data from the REGOSARC and REGOBONE trialsF Rethouze, S Risbourg, C Schiffler, et al.
Pageof 8